Nathan RA - Search Results

1

Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.

D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner P, Rennard SI. D'Alonzo GE, et al. Among authors: nathan ra. JAMA. 1994 May 11;271(18):1412-6. JAMA. 1994. PMID: 7909853 Clinical Trial.

2

The effect of repeat action albuterol sulfate (Proventil Repetabs) in nocturnal symptoms of asthma.

Storms WW, Nathan RA, Bodman SF, Morris RJ, Selner JC, Greenstein SM, Zwillich CW. Storms WW, et al. Among authors: nathan ra. J Asthma. 1992;29(3):209-16. doi: 10.3109/02770909209099029. J Asthma. 1992. PMID: 1351053 Clinical Trial.

3

Use of ipratropium bromide in asthma. Results of a multi-clinic study.

Storms WW, Bodman SF, Nathan RA, Busse WW, Bush RK, Falliers CJ, O'Hollaren JD, Weg JG. Storms WW, et al. Among authors: nathan ra. Am J Med. 1986 Nov 14;81(5A):61-6. doi: 10.1016/0002-9343(86)90464-x. Am J Med. 1986. PMID: 2947462 Free article. Clinical Trial.

4

Safety of salmeterol in the maintenance treatment of asthma.

Nathan RA, Seltzer JM, Kemp JP, Chervinsky P, Alexander WJ, Liddle R, Mills R. Nathan RA, et al. Ann Allergy Asthma Immunol. 1995 Sep;75(3):243-8. Ann Allergy Asthma Immunol. 1995. PMID: 7552926 Clinical Trial.

5

Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma.

Nathan RA, Bronsky EA, Dockhorn RJ, Kemp JP. Nathan RA, et al. Ann Allergy. 1994 Mar;72(3):209-16. Ann Allergy. 1994. PMID: 8129213 Clinical Trial.

6

Efficacy and safety of inhaled bitolterol mesylate via metered-dose inhaler in children with asthma.

Bierman CW, Kemp JP, Nathan RA. Bierman CW, et al. Among authors: nathan ra. Ann Allergy Asthma Immunol. 1996 Jan;76(1):27-35. doi: 10.1016/s1081-1206(10)63403-5. Ann Allergy Asthma Immunol. 1996. PMID: 8564625 Clinical Trial.

7

A one-week dose-ranging study of inhaled salmeterol in children with asthma.

Weinstein S, Chervinsky P, Pollard SJ, Bronsky EA, Nathan RA, Prenner B, Howland WC 3rd, Stahl E, Liddle R. Weinstein S, et al. Among authors: nathan ra. J Asthma. 1997;34(1):43-52. doi: 10.3109/02770909709071202. J Asthma. 1997. PMID: 9033439 Clinical Trial.

8

Is the tolerance to the bronchoprotective effect of salmeterol clinically relevant?

Nathan RA. Nathan RA. Ann Allergy Asthma Immunol. 1998 Jan;80(1):1-3; discussion 4. doi: 10.1016/S1081-1206(10)62929-8. Ann Allergy Asthma Immunol. 1998. PMID: 9475559 Review. No abstract available.

9

Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction.

Nathan RA, Bernstein JA, Bielory L, Bonuccelli CM, Calhoun WJ, Galant SP, Hanby LA, Kemp JP, Kylstra JW, Nayak AS, O'Connor JP, Schwartz HJ, Southern DL, Spector SL, Williams PV. Nathan RA, et al. J Allergy Clin Immunol. 1998 Dec;102(6 Pt 1):935-42. doi: 10.1016/s0091-6749(98)70331-8. J Allergy Clin Immunol. 1998. PMID: 9847434 Clinical Trial.

10

An evaluation of zafirlukast in the treatment of asthma with exploratory subset analyses.

Tashkin DP, Nathan RA, Howland WC, Minkwitz MC, Simonson SG, Bonuccelli CM. Tashkin DP, et al. Among authors: nathan ra. J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):246-54. doi: 10.1016/s0091-6749(99)70498-7. J Allergy Clin Immunol. 1999. PMID: 9949315 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results